The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes
Open accessAbstract
SUMMARY The molecular foundations of Hürthle cell carcinoma (HCC) are poorly understood. Here, we describe a comprehensive genomic characterization of 56 primary HCC tumors that span the spectrum of tumor behavior. We elucidate the mutational profile and driver mutations and show that they exhibit a wide range of recurrent mutations. Notably, we report an extremely high number of disruptive mutations to both protein-coding and tRNA-encoding regions of the mitochondrial genome. We reveal unique chromosomal landscapes that involve whole-chromosomal duplications of chromosomes 5 and 7 and widespread loss of heterozygosity arising from haploidization and copy number–neutral uniparental disomy. We also identify fusion genes and disrupted signaling pathways that may drive disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Li, H. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr509 · Cited by 6,486
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Self-citationThe Biology of Chromatin Remodeling Complexes
Clapier, C. R., & Cairns, B. R. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.062706.153223 · Cited by 2,380
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Landa, I., Ibrahimpasic, T., Boucai, L., Sinha, R., Knauf, J. A., Shah, R. H., Dogan, S., Ricarte-Filho, J. C., Krishnamoorthy, G. P., Xu, B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85271 · Cited by 1,284
Self-citationHolz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Shen, R., & Seshan, V. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw520 · Cited by 1,258
Self-citationDNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Mechanisms and functions of eph and ephrin signalling
Kullander, K., & Klein, R. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm856 · Cited by 1,156
The control of DNA repair by the cell cycle
Hustedt, N., & Durocher, D. (2017) · Nature Cell Biology · doi:10.1038/ncb3452 · Cited by 738
Shi, H., Moriceau, G., Kong, X., Lee, M.-K., Lee, H., Koya, R. C., Ng, C., Chodon, T., Scolyer, R. A., Dahlman, K. B., et al. (2012) · Nature Communications · doi:10.1038/ncomms1727 · Cited by 640
mtDNA Variation and Analysis Using Mitomap and Mitomaster
Lott, M. T., Leipzig, J. N., Derbeneva, O., Xie, H. M., Chalkia, D., Sarmady, M., Procaccio, V., & Wallace, D. C. (2013) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0123s44 · Cited by 553
Martin, M., Maßhöfer, L., Temming, P., Rahmann, S., Metz, C., Bornfeld, N., van de Nes, J., Klein-Hitpass, L., Hinnebusch, A. G., Horsthemke, B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2674 · Cited by 542
Mitochondrial DNA copy number variation across human cancers
Reznik, E., Miller, M. L., Şenbabaoğlu, Y., Riaz, N., Sarungbam, J., Tickoo, S. K., Al-Ahmadie, H. A., Lee, W., Seshan, V. E., Hakimi, A. A., et al. (2016) · eLife · doi:10.7554/elife.10769 · Cited by 530
Self-citationJun, G., Flickinger, M., Hetrick, K. N., Romm, J. M., Doheny, K. F., Abecasis, G. R., Boehnke, M., & Kang, H. M. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.09.004 · Cited by 484
Landa, I., Ganly, I., Chan, T. A., Mitsutake, N., Matsuse, M., Ibrahimpasic, T., Ghossein, R. A., & Fagin, J. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2383 · Cited by 462
Self-citationPlass, C., Pfister, S. M., Lindroth, A. M., Bogatyrova, O., Claus, R., & Lichter, P. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3554 · Cited by 453
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Montalto, G., Cervello, M., Nicoletti, F., Fagone, P., Malaponte, G., Mazzarino, M. C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.652 · Cited by 306
Shaha, A. R., Shah, J. P., & Loree, T. R. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(96)00310-8 · Cited by 262
Genomic Dissection of Hurthle Cell Carcinoma Reveals a Unique Class of Thyroid Malignancy
Ganly, I., Ricarte Filho, J., Eng, S., Ghossein, R., Morris, L. G. T., Liang, Y., Socci, N., Kannan, K., Mo, Q., Fagin, J. A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3539 · Cited by 222
Self-citationTuna, M., Knuutila, S., & Mills, G. B. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.005 · Cited by 177
Kirino, Y., Goto, Y.-I., Campos, Y., Arenas, J., & Suzuki, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500563102 · Cited by 168
Epigenetic regulation in cancer progression
Baxter, E., Windloch, K., Gannon, F., & Lee, J. S. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-45 · Cited by 164
Mitochondrial respiratory gene expression is suppressed in many cancers
Reznik, E., Wang, Q., La, K., Schultz, N. D., & Sander, C. (2017) · eLife · doi:10.7554/elife.21592 · Cited by 134
Self-citationGhossein, R. A., Hiltzik, D. H., Carlson, D. L., Patel, S. G., Shaha, A. R., Shah, J. P., Tuttle, R. M., & Singh, B. (2006) · Cancer · doi:10.1002/cncr.21825 · Cited by 132
Self-citationPathogenesis and Consequences of Uniparental Disomy in Cancer
Makishima, H., & Maciejewski, J. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2900 · Cited by 104
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
Amorim, J. P., Santos, G. S., Vinagre, J., & Soares, P. (2016) · Genes · doi:10.3390/genes7090066 · Cited by 101
Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids
Ma, Y., Bai, R., Trieu, R. B., & Wong, L. C. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.07.008 · Cited by 99
The biology and the genetics of Hürthle cell tumors of the thyroid
Máximo, V., Lima, J. P., Prazeres, H., Soares, P., & Sobrinho-Simões, M. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0354 · Cited by 93
Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations
Cercek, A., Braghiroli, M. I., Chou, J. F., Hechtman, J. F., Kemeny, N. E., Saltz, L. B., Capanu, M., & Yaeger, R. D. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0400 · Cited by 90
Wang, H., Ru, Y., Sänchez‐Carbayo, M., Wang, X., Kieft, J. S., & Theodorescu, D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3084 · Cited by 79
Lapunzina, P. D., & Monk, D. (2011) · Biology of the Cell · doi:10.1042/bc20110013 · Cited by 76
Castellana, S., Fusilli, C., Mazzoccoli, G., Biagini, T., Capocefalo, D., Carella, M., Vescovi, A. L., & Mazza, T. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005628 · Cited by 73
Hong, L., Ding, X., Zhou, C., Zhang, Y., Xu, M., Zhang, C., & Xu, L. (2012) · Neurological Sciences · doi:10.1007/s10072-011-0894-8 · Cited by 59
Genetics and epigenetics of sporadic thyroid cancer
Vu-Phan, D. L., & Koenig, R. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.030 · Cited by 58
Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas
Walsh, C., Ogawa, S., Scoles, D. R., Miller, C. W., Kawamata, N., Narod, S. A., Koeffler, H. P., & Karlan, B. Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1291 · Cited by 43
Corver, W. E., van Wezel, T., Molenaar, K., Schrumpf, M., van den Akker, B., van Eijk, R., Ruano, D., Oosting, J., & Morreau, H. M. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22194 · Cited by 39
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
Haas, M., Ormanns, S., Baechmann, S., Remold, A., Krüger, S., Westphalen, C. B., Siveke, J. T., Wenzel, P., Schlitter, A. M., Esposito, I., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.115 · Cited by 35
Xu, F., Xu, C.-Z., Gu, J., Liu, X., Liu, R., Huang, E., Yuan, Y., Zhao, G., Jiang, J., Xu, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9726 · Cited by 33
Caria, P., & Vanni, R. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.08.025 · Cited by 28
Wang, J., Ma, L., Tang, X., Zhang, X., Qiao, Y., Shi, Y., Xu, Y., Wang, Z., Yu, Y., & Sun, F. (2015) · Oncotarget · doi:10.18632/oncotarget.4373 · Cited by 26
Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer
Torabi, K., Miró, R., Fernández‐Jiménez, N., Quintanilla, I., Ramos, L., Prat, E., del Rey, J., Pujol, N., Killian, J. K., Meltzer, P. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv115 · Cited by 24
The biology and the genetics of Hürthle cell tumors of the thyroid
Máximo, V., de Lima, J. R. P., Prazeres, H., Soares, P., & Sobrinho-Simões, M. A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-11-0354a · Cited by 12
Cited by
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Baloch, Z. W., Asa, S. L., Barletta, J. A., Ghossein, R. A., Juhlin, C. C., Jung, C. K., LiVolsi, V. A., Papotti, M. G., Sobrinho-Simões, M., Tallini, G., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09707-3 · Cited by 1,158
Self-citationRingel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Boucai, L., Zafereo, M., & Cabanillas, M. E. (2024) · JAMA · doi:10.1001/jama.2023.26348 · Cited by 701
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Hmeljak, J., Sanchez-Vega, F., Hoadley, K. A., Shih, J., Stewart, C., Heiman, D., Tarpey, P., Danilova, L., Drill, E., Gibb, E. A., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0804 · Cited by 618
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Self-citation
Metadata
- Authors
- Ganly, I., Makarov, V., Deraje, S., Dong, Y., Reznik, E., Seshan, V., Nanjangud, G., Eng, S., Bose, P., Kuo, F., Morris, L. G. T., Landa, I., Carrillo Albornoz, P. B., Riaz, N., Nikiforov, Y. E., Patel, K., Umbricht, C., Zeiger, M., Kebebew, E., Sherman, E., Ghossein, R., Fagin, J. A., & Chan, T. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 34
- Issue
- 2
- Pages
- 256-270.e5
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2885688958
- Cited by
- 283
- References
- 57
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.